Neurovascular manifestations in connective tissue diseases: The case of Marfan Syndrome

Mech Ageing Dev. 2020 Oct:191:111346. doi: 10.1016/j.mad.2020.111346. Epub 2020 Sep 10.

Abstract

Patients with connective tissue diseases (CTDs) are suspected to be at higher risk for cerebrovascular involvement, such as intracranial aneurysms, dissections and strokes, than the general population. Particularly, Marfan Syndrome (MFS) has been reported as associated with an increased risk of cerebrovascular alterations. Literature data report different prevalence of intracranial aneurysms in MFS, ranging from 4 % to 29 %, suggesting a role of genetic cause that involves the regulation of the TGF-β signaling. Ischemic and hemorrhagic strokes have been also reported in MFS, but with an estimated prevalence from 3 % to 4 %. However, the aetiology of both events appears to be reliable more to a cardiac source than to the primary connective tissue defect. Finally, the available literature suggests that MFS patients have a higher prevalence of arterial tortuosity of neck and head vessels and these findings may be related to an enhanced chance of dissection. Overall, despite of the lack of studies, we could affirm that it may exists an increased prevalence of some neurovascular findings in MFS patients. Nevertheless, further studies are required to determine the true prevalence of these features and investigate specific gene mutations involved in MFS.

Keywords: Cervical arteries tortuosity; Connective tissue diseases; Dissection; Intracranial aneurysms; Marfan Syndrome; Neurovascular diseases.

Publication types

  • Review

MeSH terms

  • Arteries / abnormalities
  • Arteries / metabolism
  • Arteries / pathology
  • Hemorrhagic Stroke / epidemiology
  • Hemorrhagic Stroke / metabolism*
  • Hemorrhagic Stroke / pathology
  • Humans
  • Intracranial Aneurysm / epidemiology
  • Intracranial Aneurysm / metabolism*
  • Ischemic Stroke / epidemiology
  • Ischemic Stroke / metabolism*
  • Ischemic Stroke / pathology
  • Joint Instability / epidemiology
  • Joint Instability / metabolism
  • Joint Instability / pathology
  • Marfan Syndrome / epidemiology
  • Marfan Syndrome / metabolism*
  • Marfan Syndrome / pathology
  • Prevalence
  • Signal Transduction*
  • Skin Diseases, Genetic / epidemiology
  • Skin Diseases, Genetic / metabolism
  • Skin Diseases, Genetic / pathology
  • Transforming Growth Factor beta*
  • Vascular Malformations / epidemiology
  • Vascular Malformations / metabolism
  • Vascular Malformations / pathology

Substances

  • Transforming Growth Factor beta

Supplementary concepts

  • Arterial Tortuosity Syndrome